The systemic inflammatory response syndrome

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-0-323-47661-4.00019-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarkers

  2021cited by this paper
• Occurrence of the adult respiratory distress syndrome in neutropenic patients.

  2015cited by this paper
• Hypertonic stress regulates T cell function via pannexin‐1 hemichannels and P2X receptors

  2010cited by this paper
• Sepsis-induced myocardial depression is associated with transcriptional changes in energy metabolism and contractile related genes: A physiological and gene expression-based approach*

  2010cited by this paper
• Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target

  2010cited by this paper
• Pathomechanisms of myocardial dysfunction in sepsis.

  2010cited by this paper
• Use of Plasma Procalcitonin Levels as an Adjunct to Clinical Microbiology

  2010cited by this paper
• PATHOPHYSIOLOGICAL ROLES OF PEROXYNITRITE IN CIRCULATORY SHOCK

  2010cited by this paper
• Disseminated intravascular coagulation in burn injury.

  2010cited by this paper
• Inhibition of lung permeability changes after burn and smoke inhalation by an anti-interleukin-8 antibody in sheep

  2009cited by this paper
• Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.

  2009cited by this paper
• Discovery of the nitric oxide signaling pathway and targets for drug development.

  2009cited by this paper
• Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury

  2009cited by this paper
• Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis

  2009cited by this paper
• Clinical Evaluation of Proinflammatory Cytokine Inhibitors (sTNFR I, sTNFR II, IL‐1 ra), Anti‐inflammatory Cytokines (IL‐10, IL‐13) and Activation of Neutrophils after Burn‐induced Inflammation

  2008cited by this paper
• INCREASING PERCENT BURN IS CORRELATED WITH INCREASING INFLAMMATION IN AN ADULT RODENT MODEL

  2008cited by this paper
• Neuronal nitric oxide synthase inhibition attenuates cardiopulmonary dysfunctions after combined burn and smoke inhalation injury in sheep

  2008cited by this paper
• The role of the bronchial circulation in the acute lung injury resulting from burn and smoke inhalation.

  2007cited by this paper
• Innate response to self-antigen significantly exacerbates burn wound depth

  2007cited by this paper
• Heat shock proteins: linking danger and pathogen recognition

  2007cited by this paper
• Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome

  2006cited by this paper
• The burn edema process: current concepts.

  2005cited by this paper
• Plasma cyclic guanosine 3′–5′ monophosphate concentrations and low vascular resistance in human septic shock

  2005cited by this paper
• International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics*

  2005cited by this paper
• The cholinergic anti-inflammatory pathway.

  2005cited by this paper
• It takes nerve to dampen inflammation

  2005cited by this paper
• Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

  2004cited by this paper
• Burn Injury Initiates a Shift in Superantigen-Induced T Cell Responses and Host Survival1

  2004cited by this paper
• Injury Primes the Innate Immune System for Enhanced Toll-Like Receptor Reactivity1

  2003cited by this paper
• Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model.

  2003cited by this paper
• The protein C pathway.

  2003cited by this paper
• The rediscovery and isolation of TFPI

  2003cited by this paper
• Research on complement: old issues revisited and a novel sphere of influence.

  2003cited by this paper
• Corticosteroid insufficiency in acutely ill patients.

  2003cited by this paper
• 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

  2003cited by this paper
• Deficient transforming growth factor beta and interleukin-10 responses contribute to the septic death of burned patients.

  2002cited by this paper
• Antithrombin III in patients admitted to intensive care units: a multicenter observational study

  2002cited by this paper
• Activated Protein C Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production by Inhibiting Activation of both Nuclear Factor-κB and Activator Protein-1 in Human Monocytes

  2002cited by this paper
• The cellular basis of post-burn immunosuppression: macrophages and mediators.

  2002cited by this paper
• Regulation of inflammatory responses by natural anticoagulants

  2001cited by this paper
• Activation of Monocytes and Endothelial Cells Depends on the Severity of Surgical Stress

  2000cited by this paper
• Procalcitonin: new insights on regulation and origin.

  2000cited by this paper
• HMG-1 as a late mediator of endotoxin lethality in mice.

  1999cited by this paper
• A regional medical center's experience with burns of the elderly.

  1999cited by this paper
• Protective effects of C5a blockade in sepsis

  1999cited by this paper
• An overview of tumor necrosis factor α and the failing human heart

  1999cited by this paper
• CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS

  1999cited by this paper
• Systemic inflammatory response syndrome in the trauma intensive care unit: who is infected?

  1999cited by this paper
• The C-reactive protein.

  1999cited by this paper
• Stretch-induced mitogen-activated protein kinase activation and interleukin-8 production in type II alveolar cells.

  1999cited by this paper
• Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis.

  1999cited by this paper
• Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits.

  1999cited by this paper
• Endothelium-Derived Relaxing Factor: Discovery, Early Studies, and Identification as Nitric Oxide

  1999cited by this paper
• Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness: effect of intensive care unit resuscitation.

  1999cited by this paper
• Immunonutrition in the critically ill: a systematic review of clinical outcome.

  1999cited by this paper
• Immune dysfunction in trauma.

  1999cited by this paper
• Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome.

  1999cited by this paper
• Differential expression of tumor necrosis factor receptor subtypes on leukocytes in systemic inflammatory response syndrome.

  1999cited by this paper
• Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

  1998cited by this paper
• Evaluation of systemic inflammatory response syndrome criteria as a predictor of mortality in emergency patients transported by ambulance.

  1998cited by this paper
• Lipid Mediators in Inflammatory Disorders

  1998cited by this paper
• Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group.

  1998cited by this paper
• Plasma tumor necrosis factor-α, its soluble receptors and interleukin-1β levels in critically burned patients

  1998cited by this paper
• Objective estimates of the probability of death from burn injuries.

  1998cited by this paper
• Time course of immunological markers in patients with the systemic inflammatory response syndrome: evaluation of sCD14, sVCAM‐1, sELAM‐1, MIP‐1α and TGF‐β2

  1998cited by this paper
• Nuclear factor k B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy

  1998cited by this paper
• Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome.

  1998cited by this paper
• Death in the burn unit: sterile multiple organ failure.

  1998cited by this paper
• Mechanisms and clinical implications of apoptosis.

  1998cited by this paper
• Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial.

  1998cited by this paper
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients.

  1997cited by this paper
• Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.

  1997cited by this paper
• Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study Group.

  1997cited by this paper
• Therapies for sepsis. Emerging therapies for sepsis and septic shock.

  1997cited by this paper
• Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80% TBSA burns (> or = 70% full-thickness).

  1997cited by this paper
• Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis.

  1997cited by this paper
• Nitric Oxide in the Vasculature: Physiology and Pathophysiology

  1997cited by this paper
• Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.

  1997cited by this paper
• HYPERTONIC SALINE RESUSCITATION: A TOOL TO MODULATE IMMUNE FUNCTION IN TRAUMA PATIENTS?

  1997cited by this paper
• Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?

  1997cited by this paper
• The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group.

  1997cited by this paper
• Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock

  1997cited by this paper
• Role of NFkappaB in the mortality of sepsis.

  1997cited by this paper
• Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery.

  1997cited by this paper
• Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNFα plasma concentrations

  1997cited by this paper
• Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment.

  1997cited by this paper
• Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.

  1996cited by this paper
• Circulating levels of tumour necrosis factor, interleukin 6 and proteolytic activity in a murine model of burn and infection.

  1996cited by this paper
• Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome.

  1996cited by this paper
• The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.

  1995cited by this paper
• Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury.

  1995cited by this paper
• Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

  1995cited by this paper
• Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcomes in surgical ICU patients

  1995cited by this paper
• Platelet‐activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double‐blind, placebo‐controlled, multicenter clinical trial

  1994cited by this paper
• Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia

  1994cited by this paper
• Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial

  1994cited by this paper
• Effects of a nitric oxide synthase inhibitor in humans with septic shock.

  1994cited by this paper
• Plasma degradation of platelet‐activating factor in severely ill patients with clinical sepsis

  1994cited by this paper
• Bacterial Translocation in Burns

  1993cited by this paper
• Availability of tetrahydrobiopterin is not a factor in the inability to detect nitric oxide production by human macrophages.

  1993cited by this paper

• Assessment of trace elements in critically ill patients with systemic inflammatory response syndrome: A systematic review.

  2023cites this paper
• Multicentre observational study describing the systemic response to small-area burns in children.

  2020cites this paper
• Mesenchymal stem cell therapy of acute thermal burns: A systematic review of the effect on inflammation and wound healing.

  2020cites this paper
• Pregnancy, Viral Infection, and COVID-19

  2020cites this paper
• SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It?

  2020cites this paper
• Does Neutrophil Phenotype Predict the Survival of Trauma Patients?

  2019cites this paper
• The Effects of Two Different Burn Dressings on Serum Oxidative Stress Indicators in Children with Partial Burn.

  2019cites this paper
• Microdialysis Workflow for Metabotyping Superficial Pathologies: Application to Burn Injury

  2019cites this paper
• Hypocoagulation induced by broad-spectrum antibiotics in extensive burn patients

  2019cites this paper
• Investigating the relationship between microalbuminuria and prognosis of patients with severe burns in the Motahari Burn Hospital.

  2017cites this paper
• Clinical and Laboratorial Changes in Horses Subjected to a High-Pressure Modified Model of Small Colon Distention

  2016cites this paper
• INVESTIGATING THE RELATIONSHIP BETWEEN MICROALBUMINURIA AND PROGNOSIS OF PATIENTS WITH SEVERE BURNS IN THE MOTAHARI BURN HOSPITAL

  year unknowncites this paper